Business Merck Wins FDA Approval for First Oral PCSK9 Inhibitor Cholesterol Pill July 16, 2026 Merck announced on Thursday that the U.S. Food and Drug Administration has approved Lipfendra, marking a historic first for cholesterol treatment. The pill represents the inaugural oral PCSK9 inhibitor to…
Health Hidden Liver Protein Controls Cholesterol and Heart Disease Risk May 25, 2026 Scientists Identify Master Switch for Cholesterol Control Researchers at UT Southwestern Medical Center identified a protein that acts as a key regulator. This protein controls how the liver releases cholesterol…